SOFT CAPSULE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Global Soft Capsule Market Size and Forecast – 2026 To 2033

The global soft capsule market is expected to grow from USD 8,827.2 Mn in 2026 to USD 14,873.3 Mn by 2033, registering a compound annual growth rate (CAGR) of 7.7% from 2026 to 2033. The market for soft capsule is poised for significant expansion, fueled by an increased global demand for dietary supplements and preventive health products.

According to the U.S. Food and Drug Administration (FDA), the dietary supplement market is worth more than USD 60 billion, with as many as 100,000 different products available to consumers. This reflects the substantial scale and continued expansion of the dietary supplement industry.

(Source: Food and Drug Administration)

Key Takeaways of the Global Soft Capsule Market

• Gelatin Softgel Capsule is projected to hold 78.2% of the global soft capsule market share in 2026, making it dominant product type segment, across North America due to high consumer acceptance and usage of dietary supplements; high penetration of softgel dosage form for vitamin, mineral, and omega-3 products. For instance, according to the U.S. Centers for Disease Control and Prevention (CDC), during August 2021–August 2023, 35.7% of youth aged 0–19 years and 60.2% of adults aged 20 and older used any dietary supplement. (Source: Centers for Disease Control and Prevention) This reflects the consistent demand of delivery formats for supplement. The trend of supplement consumption, especially in softgel forms, directly increases the demand for gelatin softgels due to their advantageous bioavailability, convenience to swallow and economic production costs.
• Hydroxy propyl methyl cellulose (HPMC) is projected to hold 52.3% of the global soft capsule market share in 2026, making it dominant source type segment, across Europe due to growing consumer demand for plant based and vegetarian supplement formulations. For instance, the European Commission's Farm to Fork Strategy advocates for sustainable food consumption and a transition towards healthier and more sustainable food diets across the European Union. (Source: European Commission) Such policy initiatives have accelerated the use of vegan nutraceuticals, and the growing demand for vegan HPMC soft capsules is replacing animal-based gelatin soft capsules.
• Health supplements are projected to hold 30.4% of the global soft capsule market share in 2026, making it dominant application segment, across Asia Pacific due to increasing emphasis on health, growing preventive healthcare expenditure, and government nutrition programs. For instance, India’s POSHAN Abhiyaan (National Nutrition Mission) promotes nutrition improving activities through around 14 lakh Anganwadi Centres and around 9 crore beneficiaries through the Poshan Tracker platform. (Source: Ministry of Women and Child Development) These government-supported nutrition programs are creating awareness for micronutrient requirements and food supplementation, leading to increased consumption of vitamins, minerals, and wellness supplements, often delivered in soft capsule formulations.
• Europe market maintains dominance with an expected share of 31.4% in 2026, bolstered by increasing aging population of the region, developed nutraceutical industry and growing attention on preventive health. For instance, according to Eurostat, individuals aged 65 years and over accounted for 21.6% of the EU population in 2024. (Source: European Commission) The rising elderly population is the leading factor in raising the demand for dietary supplements, cardiovascular health products, bone and joint health formulations, and healthy aging products, which further increases the use of soft capsule dosage forms across the region.
• Asia Pacific is expected to exhibit the fastest growth with an estimated contribution of 27.1% share in 2026, fueled by rising healthcare expenditure, rise in disposable income, and increased government backing for nutraceutical industry. For instance, The Healthy China 2030 campaign in China is dedicated towards promoting health and disease prevention, and the government calls for more public engagement in healthy management and nutrition enhancement projects. (Source: ScienceDirect) These initiatives are educating consumers on dietary supplements and preventive healthcare, which is leading to accelerated demand for soft capsule-based formulations throughout the region.
• Rising Adoption of Plant-Based and Vegan Soft Capsules: The shift towards vegan and clean-label ingredients is a key opportunity for plant-based soft capsule manufacturers. Since traditional gelatin capsules are unsuitable for vegetarian, vegan, halal and kosher diets, more manufacturers will be looking to use HPMC and other vegetarian raw materials. The broad availability of vegan products by nutraceutical and pharmaceutical companies will likely stimulate quick adoption of non-animal-derived soft capsules in the near future. Europe and North America are likely to lead in the market growth due to consumer demand for plant-based, clean label and cruelty-free products which leads manufacturers to replace the use of gelatin capsules. This opens a new route for premium pricing and brand positioning.
• Expansion of Personalized Nutrition and Precision Supplementation: Driven by breakthroughs in digital health technologies, biomarker testing and consumer health monitoring, personalization is taking hold of nutritional solutions. Customized supplementations in the form of softgels are now being designed with precise formulas comprising vitamin, mineral, probiotic, omega-3 and special ingredient blends according to individual health profiles. The versatility of softgel technology supports the development of highly specific doses and combined delivery of various actives. It has the capacity to support the demand for personalized wellness products. This is likely to create new sources of revenue in the top-end nutraceutical and preventative healthcare market.

Segmental Insights

To learn more about this report, Request Free Sample

Why Does Gelatin Softgel Capsule Dominate the Global Soft Capsule Market?

Gelatin softgel capsule is projected to hold the market share of 78.2% in 2026, due to its improved liquid and semi-solid formulation capabilities, superior bioavailability, and acceptance in pharmaceutical and nutraceutical markets. Its mature manufacturing technology and established regulatory approval is preferred by both pharmaceutical and supplement manufacturers. For instance, the U.S. Food and Drug Administration (FDA) granted approval for the expanded indication of Vascepa (icosapent ethyl), a softgel capsule formulation used for cardiovascular risk management, reinforcing the preference of the softgel-based drug delivery system within the pharmaceutical industry. These regulatory approvals affirm the segment’s performance and efficacy which in turn will guarantee the demand for gelatin softgel capsule globally.

Why Does Hydroxy Propyl Methyl Cellulose (HPMC) Represent the Largest Source Type Segment in the Soft Capsule Market?

To learn more about this report, Request Free Sample

Hydroxy Propyl Methyl Cellulose (HPMC) is projected to hold a market share of 52.3% in 2026, due to its vegetarian origin, high stability, and its suitability for use in vegetarian, vegan, halal and kosher formulation. HPMC capsules have low moisture content and is well suited for encapsulation of hygroscopic and moisture-sensitive substances, making them increasingly favorable for use in the nutraceutical and pharmaceutical industry. The increasing consumer preference for clean-label and animal-free supplements has been driving the rapid uptake of plant-derived capsule technologies across the nutraceutical industry. The segment's growth is being further boosted by increasing investments in plant-based capsule technologies. For instance, Sirio Pharma introduced its Plantegrity plant-based softgel series utilizing its in-house gellan gum technology to meet consumer demand for a sustainable capsule option that does not rely on animal-derived raw materials. This novel solution boasts excellent heat and humidity resistance, lower cross-linking, and better nutrient protection, illustrating the sector's increased interest in novel plant-based capsule solutions. (Source: Sirio Pharma)

Health Supplements Segment Dominates the Global Soft Capsule Market

The health supplements segment is projected to hold a market share of 30.4% in 2026, attributed to growing consumer awareness towards preventive care, wellness and dietary supplementation. Soft capsules are favored for the delivery of vitamins, omega-3 fatty acids, probiotics, and herbal extracts owing to their enhanced bioavailability and easier consumption than solid dosage forms, besides their suitability to encapsulate oil-based formulations. The surging demand for immunity, healthy aging and general wellness products are further boosting the segment’s growth. For instance, The Council for Responsible Nutrition (CRN)'s 2024 Consumer Survey revealed that 75% of U.S. adults use dietary supplements, which represents the continued adoption of nutritional products in the consumers' diet. (Source: Council for Responsible Nutrition) An increase in the consumption of dietary supplements continues to fuel demand for soft capsule formations on a global scale.

Currents Events and their Impact

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

(Source: Food and Drug Administration, European Commission)

Soft Capsule Market Dynamics

To learn more about this report, Request Free Sample

Market Drivers

• Rising demand for nutraceuticals and dietary supplements: The increasing consumer demand for preventive healthcare and wellness has led to high growth potential for nutraceuticals and dietary supplements in the recent past providing a major growth drive for soft capsule market. Soft capsules are a favored dosage form for administration of vitamins, herbal extracts, omega-3 fatty acids and other bio-actives owing to their bioavailability and ease of swallowing. Growing consciousness for immunity, healthy aging, and lifestyle disease management is promoting supplement consumption globally. For instance, in October 2025, a study published by National Library of Medicine, reported that the overall use of any dietary supplements increased from 51.8% in 2011-2012 to 61.4% in 2021-2023, highlighting growing consumer reliance on nutritional supplementation. (Source: National Library of Medicine) Thus, the continued upward trend in supplement intake should promote a sustained demand for soft capsule formulations.
• Increasing preference for softgels: The rising consumer inclination towards softgels is a major growth catalyst for the global soft capsule market. Softgels are known to provide higher bioavailability, easier swallowing benefits, and provide fat-soluble and liquid actives easier dosage forms than traditional tablets and powders. Softgels are able to cover foul-tasting and foul-smelling actives thereby enabling higher patient and consumer compliance across pharmaceutical and nutraceutical applications. For instance, Catalent's OptiGel softgel technology remains a popular choice for many pharmaceutical and consumer health companies in enhancing bioavailability and consumer acceptance for difficult-to-formulate compounds, although interest in the industry is increasingly focused on other softgel technology newer on the market. (Source: Catalent, Inc) The market is expected to grow in the next few years as softgel technology gains momentum.

Emerging Trends

• Development of Multi-Active and Combination Softgel Formulations: Multi-active soft capsules (a combination of several vitamins, minerals, probiotic bacteria, omega-3 fatty acids, and botanicals) are being increasingly developed by manufacturers. These types of formulations fulfill consumers’ need for convenience, and at the same time, the brands offer an ideal approach to targeted therapies for immunity, cognition, cardiovascular health, and healthy aging.
• Growing Penetration of Soft Capsules in Functional and Beauty-from-Within Supplements: The use of soft capsules for premium nutraceutical solutions, including collagen, biotin, astaxanthin, coenzyme Q10, and skin-health products, is predicted to become an important area of growth within the softgel sector in the coming years. Consumer focus on health-from-within and multifunctional health products is expected to prompt wider adoption of softgel delivery technology outside the pharmaceutical sector.

Regional Insights

To learn more about this report, Request Free Sample

Why is Europe a Strong Market for Soft Capsule?

Europe leads the global soft capsule market, accounting for an estimated 31.4% share in 2026, driven by mature nutraceutical and pharmaceutical sector, increasing emphasis on proactive health and wellness, and a demand for high-value health and wellness supplements. Increasing consumption of vitamins, omega-3s, botanical extracts and healthy aging products-all frequently delivered in a soft capsule matrix-has been witnessed. Consumer trend of lean-label, plant-derived and scientifically proven products is encouraging innovation in softgel technologies. For instance, Under the EU-sponsored PRIMA (Partnership for Research and Innovation in the Mediterranean Area) programme the EU will continue to facilitate research work into healthy nutrition, balanced diets and food innovation, thereby advancing innovative nutraceutical product developments throughout the region. (Source: European Commission) Such initiatives are expected to boost the demand for soft capsule formulations across Europe.

Why Does Asia Pacific Soft Capsule Market Exhibit High Growth?

The Asia Pacific soft capsule market is expected to exhibit the fastest growth with an estimated contribution of 27.1% share to the global market in 2026, due to increased health consciousness, growing disposable income, increase in consumption of nutraceuticals, and fast developing pharmaceuticals and consumer healthcare sector across China, India, Japan, and Southeast Asia. Additionally, manufacturers are increasingly expanding production capacity and are introducing premium range of supplement formulations to meet the changing needs of the consumers. For instance, Japan's Ministry of Health, Labour and Welfare (MHLW) continued the development of the Foods with Function Claims (FFC) framework allowing companies to put functionally documented foods and dietary supplements onto the market on a notification basis with no further proceedings. (Source: RegASK) The framework has led to product innovation and development of functional nutrition products, many of which utilize soft capsule delivery systems.

Global Soft Capsule Market Outlook for Key Countries

Why is the U.S. Leading Innovation and Adoption in the Soft Capsule Market?

The U. S. is at the forefront of innovation and adoption in the soft capsule market driven by mature consumer health system and the highest concentration of softgel manufacturers (such as Catalent, Captek Softgel International, Soft Gel Technologies Inc.), CDMOs (such as Catalent, Thermo Fisher Scientific–Patheon, Aenova's U.S. operations) and nutraceutical brands (such as Nature's Bounty, Garden of Life, NOW Foods, Nature Made). Advanced softgel technology with improved bioavailability, delayed-release capsules, and multi-ingredient softgels are being commercialized more quickly than any other country. With a fully developed dietary supplement industry, new health ingredients are being rapidly adapted into innovative softgel formulations, from preventive health to sports nutrition to healthy aging applications.

Is Japan a Favorable Market for Soft Capsule Market?

Japan is one of the most promising markets for the soft capsule market owing to mature pharmaceutical and nutraceutical markets in addition to high consumer acceptance of easier-to-swallow products and high value of quality health/beauty orientated products. Soft capsules are generally used in Japan for omega-3 products, functional foods, performance nutrition, beauty-from-within and vitamins, as they easily maintain the form of the liquid active ingredients. Moreover, Japan's strong emphasis on product quality and innovation of functional nutrition as well as increasing health consciousness for aging will propel further adoption of advanced soft capsule technologies in the pharmaceutical as well as supplement markets.

Is China Emerging as a Key Growth Hub for the Soft Capsule Market?

China is positioned as a key growth hub in the global soft capsule market as a result of a highly progressive nutraceutical industry, rising consumer awareness about preventive healthcare and a significant domestic manufacturing strength. The country is highly recognized as a manufacturing base for dietary supplements, functional nutrition products and softgel OEM manufacturing for both local and export markets. Increasing consumer demand for immunity, healthy aging & wellness products and investments in most advanced capsule encapsulation and higher end formulation investments are contributing to increased adoption of soft gel capsules in China.

Why Does Germany Top the European Soft Capsule Market?

Germany is the leader in the European market for soft capsule driven by a solid pharmaceutical manufacturing base and well-established nutraceutical processing facilities catering to a consumer market with an insatiable appetite for finest quality health and wellness products. The country is one of the largest manufacturers of vitamins, dietary supplements, and specialized products resulting in long-term demand for specialty filling and encapsulation technologies, including softgel solutions. Targeted contract manufacturing and pharmaceutical companies pushing capsule production ahead have resulted in Germany being a pioneer in encapsulation technology investments.

Is Soft Capsule Market Developing in India?

India soft capsule market shows immense potential driven by rapid expansion of nutraceutical, dietary supplement and consumer health care. The surging need for immune enhancement products, protein supplements, omega-3 solutions, and preventive health care products is inspiring the softgel manufacturers in boosting their production capacity. Simultaneously the country is establishing itself into a prominent contract manufacturer which is backed by low manufacturing cost, pharmaceutical business ecosystem and emerging investments in developing nutraceutical products. For instance, Recognizing the nutraceutical sector’s immense potential, the Council of Scientific and Industrial Research (CSIR) constituted a Nutraceutical Sector Task Force (TF) to identify policy measures and avenues for the growth of the nutraceutical industry. The task force suggested measures such as separate HSN code for nutraceuticals, a Production-Linked Incentive (PLI) scheme, export promotion strategies and setting up nutraceutical incubation centers to promote domestic production and innovation. (Source: Press Information Bureau)

Regional Nutraceutical and Dietary Supplement Consumption Landscape Supporting Soft Capsule Demand

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

How is the growing adoption of vegan and plant-based soft capsule formulations creating new growth opportunities in the soft capsule market?

The increasing transition towards vegan and plant-based soft capsule formulations presents attractive potential growth areas within the soft capsule market, as consumer demand for eco-friendly, and clean-label animal-free health products continues to increase. Vegetarian and vegan consumers; Halal and Kosher consumers and ultimately the wider consumer base, are being drawn to the offerings of plant-based capsules, which offer solutions to animal-derived ingredients and complement non-meat diets. This is prompting manufacturers to develop supplements comprised of non-gelatin capsule solutions and look toward new plant-based options. For instance, in 2025, collaborative research by YouGov and Veganuary calculated that approximately 25.8 million people globally tried veganism in January 2025, emphasizing the increasing consumer adoption of plant-based lifestyles. (Source: The Vegan Society) This expanding vegan consumer base is likely to increase the global demand for vegan, plant-based soft capsule solutions across nutraceutical and pharmaceutical applications.

Market Players, Key Development, and Competitive Intelligence

To learn more about this report, Request Free Sample

Key Developments

• In May 2026, Lotus Pharmaceutical launched Nintedanib on a global scale in 30 markets and broadened the range of specialty pharmaceutical products available for its use. Nintedanib is primarily used to treat idiopathic pulmonary fibrosis and other interstitial lung diseases usually delivered in capsule form. The launch illustrates the emerging requirement for innovative drug delivery technologies and will likely promote the growth of the global soft capsule manufacturing market.
• In May 2024, Roquette launched LYCAGEL Flex, a novel hydroxypropyl pea starch-based softgel capsule shell system designed for nutraceutical and pharmaceutical applications. The new formulation provides increased flexibility in softgel manufacturing as well as responds to the growing demand for plant-based and non-gelatin capsule alternatives. This launch was set to facilitate innovation within soft capsule formulation and open up possibilities for the vegan supplements segment.

Competitive Landscape

The global soft capsule market is moderately fragmented, with the existing softgel manufacturers, contract development and manufacturing organizations (CDMOs) along with nutraceutical solutions providers. Companies are actively competing to meet the rising requests from pharmaceutical and dietary supplement industries by innovating softgel formulation technology and portfolio, along with increasing manufacturing capacity. Strategic partnerships along with acquisitions and geographic expansion are the other prominent strategies applied by market players. Key focus areas include:

• Development of advanced softgel technologies
• Expansion of plant-based and vegan soft capsule offerings
• Strengthening CDMO and contract manufacturing capabilities
• Strategic partnerships, capacity expansions, and product innovations

Market Report Scope

Soft Capsule Market Report Coverage

Analyst Opinion (Expert Opinion)

• The soft capsule market is predicted to experience sustained growth over the next few years, as consumers are increasingly seeking out preventive healthcare, healthy aging and nutritional support. The demand is likely to rise for more advanced products and formulations, including immune support, cognitive health, beauty-from-within, sports nutrition and metabolic health, in addition to the conventional vitamin and mineral supplements. Moreover, rising popularity of vegan and clean-label formulas will drive innovation in capsule materials and delivery technologies.
• The maximum opportunities will probably exist within health supplements applications, especially as China, India and the U.S. experienced increased health consciousness, growing middle class and supplement consumption as the market grew at a rapid pace. Plant-based soft capsules and premium nutraceuticals targeting personalized nutrition, healthy ageing and preventative health are expected to be the most promising within the forecast.
• In order to obtain a competitive advantage, market participants should focus on establishing more leverage on building up plant-based soft capsule range, increasing strategic investments on next-generation formulation technology for enhanced bioavailability and robust stability, along with building stronger, long-term partnership with nutraceutical and consumer health brands. Focusing on delivery system innovation and expansion of manufacturing scale and supporting ingredients customization services should enable market player to address future opportunities.

Market Segmentation

• Product Type Insights (Revenue, USD Mn, 2021 - 2033)
  • Gelatin Softgel Capsule
  • Non-gelatin Softgel Capsule
• Source Type Insights (Revenue, USD Mn, 2021 - 2033)
  • Gelatin Type-A
  • Gelatin Type-B
  • Hydroxy Propyl Methyl Cellulose (HPMC)
  • Others
• Application Insights (Revenue, USD Mn, 2021 - 2033)
  • Health Supplements
  • Antibiotic Drugs
  • Cardiovascular Drugs
  • Anti-inflammatory Drugs
  • Others
• End User Insights (Revenue, USD Mn, 2021 - 2033)
  • Pharmaceutical Companies
  • Contract Manufacturing Organizations
  • Nutraceutical Companies
  • Others
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Catalent, Inc.
  • Lonza Group AG
  • Procaps Group
  • Aenova Group
  • Sirio Pharma Co., Ltd.
  • EuroCaps Ltd.
  • CAPTEK Softgel International
  • Fuji Capsule Co., Ltd.
  • MEDGEL Co., Ltd.
  • Soft Gel Technologies, Inc.

Sources

Primary Research Interviews

• Soft capsule and softgel manufacturing executives
• Nutraceutical product development and formulation specialists
• Pharmaceutical dosage form development managers
• Contract Development & Manufacturing Organizations (CDMOs) specializing in softgel production
• Dietary supplement brand owners and procurement managers
• Raw material suppliers (gelatin, HPMC, gellan gum, carrageenan, excipients)

Stakeholders

• Soft capsule and softgel manufacturers
• End-use Sectors
  • Health supplements manufacturers
  • Pharmaceutical companies
  • Nutraceutical companies
  • Sports nutrition companies
  • Functional nutrition and wellness brands
  • Beauty-from-within and nutricosmetic companies
  • Veterinary supplement manufacturers
  • Contract Development & Manufacturing Organizations (CDMOs)
• Regulatory & Health Bodies
  • U.S. Food and Drug Administration (FDA)
  • European Medicines Agency (EMA)
  • European Food Safety Authority (EFSA)
  • Food Standards Agency (FSA), UK
  • Food Safety and Standards Authority of India (FSSAI)
  • National Medical Products Administration (NMPA), China
  • Therapeutic Goods Administration (TGA), Australia

Databases

• FDA Dietary Supplement Ingredient Directory
• NIH Office of Dietary Supplements (ODS)
• ClinicalTrials.gov
• FDA Drug Approval Database
• European Commission Novel Food Catalogue
• Eurostat Health Database
• WHO Global Health Observatory
• OECD Health Statistics

Magazines

• Nutraceutical Business Review
• Natural Products Insider
• Nutritional Outlook
• Nutraceuticals World
• Nutrition Industry Executive
• Pharmaceutical Technology
• The Medicine Maker

Journals

• Journal of Dietary Supplements
• International Journal of Food Sciences and Nutrition
• Journal of Functional Foods
• European Journal of Nutrition

Newspapers

• Financial Times – healthcare and consumer health coverage
• The Wall Street Journal – pharmaceutical and supplement industry developments
• Nikkei Asia – nutraceutical and consumer health trends
• The Economic Times – healthcare and nutraceutical industry developments
• China Daily – pharmaceutical and dietary supplement sector coverage

Associations

• Council for Responsible Nutrition (CRN)
• Consumer Healthcare Products Association (CHPA)
• International Alliance of Dietary/Food Supplement Associations (IADSA)
• Natural Products Association (NPA)
• American Herbal Products Association (AHPA)
• Food Supplements Europe (FSE)
• United Natural Products Alliance (UNPA)

Public Domain Sources

• U.S. Food and Drug Administration (FDA)
• National Institutes of Health (NIH) – Office of Dietary Supplements
• World Health Organization (WHO)
• European Commission
• Eurostat
• Food Safety and Standards Authority of India (FSSAI)
• National Medical Products Administration (NMPA), China

Proprietary Elements

• CMI Data Analytics Tool, Proprietary CMI Existing Repository of information for last 10 years.